“Bimekizumab Efficacy by Prior Biologic Treatment in Patients With Moderate to Severe Hidradenitis Suppurativa: 48-Week Pooled Data from the Randomized, Double-Blind, Placebo-Controlled, Multicenter BE HEARD I and II Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s349. Accessed May 14, 2025. https://skin.dermsquared.com/skin/article/view/2449.